Andrew Schutte
Chief Executive Officer presso REPLICEL LIFE SCIENCES INC.
Patrimonio netto: 779 004 $ in data 31/03/2024
Profilo
Andrew Schutte is currently the President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc. He is also the President at Nolan Olbohrung, LLC and Valence Oil LLC.
Previously, he served as the Chief Technology Officer at MainPointe Pharmaceuticals LLC from 2016 to 2022.
Prior to that, he worked as a VBA Programmer at Gerimed, Inc. from 2012 to 2016.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REPLICEL LIFE SCIENCES INC.
26.77% | 16/08/2023 | 17 401 616 ( 26.77% ) | 765 671 $ | 31/03/2024 |
| 16/08/2023 | 303 030 ( 27.82% ) | 13 333 $ | 31/03/2024 |
Posizioni attive di Andrew Schutte
| Società | Posizione | Inizio |
|---|---|---|
| REPLICEL LIFE SCIENCES INC. | Chief Executive Officer | 28/11/2022 |
| Nolan Olbohrung, LLC | President | - |
| Valence Oil LLC | President | - |
Precedenti posizioni note di Andrew Schutte
| Società | Posizione | Fine |
|---|---|---|
MainPointe Pharmaceuticals LLC
 MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| Gerimed, Inc. | Corporate Officer/Principal | 01/02/2016 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REPLICEL LIFE SCIENCES INC. | Health Technology |
| Aziende private | 4 |
|---|---|
MainPointe Pharmaceuticals LLC
MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Distribution Services |
| Gerimed, Inc. | |
| Nolan Olbohrung, LLC | |
| Valence Oil LLC |
- Borsa valori
- Insiders
- Andrew Schutte
